Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

Dell and DOE Talk Partnering on Building AI Infrastructure
10:15

Mattel CEO Ynon Kreiz Talks Toy Industry, Supply Chain
08:24

US Olympic Silver Medalist Korey Dropkin Talks Curling, Rock League
09:02